Harbin Sequel Bio-Engineering Pharmaceutical Co., Ltd.

Update this listing     Add your free listing
Phone
86-28-875...
Country
ChinaChina
Address
No. 64o
Airport Raod Of Daoli District
Harbin Heilongjiang
[Zip/Postal Code:150078]

Is this your business? Update this listing

Company Description

Harbin Sequel Bio-Engineering Pharmaceutical Co., Ltd., is one of the best blood products manufacturer in China firstly passed attestation by GMP Attestation Committee of the peoples republic of China, which is also the first-batch blood products production enterprise designated by the State Ministry of Health of China. It has perfect quality guarantee system, strict test system and modern test method, possesses advanced production equipment(mainly imported from Japan and Sweden and etc. ) and advanced production technology. Strong technical capability and various talent specialists who with products comprehensive research & development ability and production ability are the best guarantee for high-quality products. The quality of our products meets or even surpasses the requirements of BP and USP. Our main products are Human Albumin, Human Immunoglobulin, Lyophilized Human Immunoglobulin(Ph4)for Intravenous Injection, Human Intravenous Immunoglobulin(IVIG, Liquid form), and Lyophilized Human Fibrinogen. (with complete specifications) The quality of our products is stable and reliable, 100% up to standard in many spot checks by NICPBP(National Institute for the Control of Pharmaceutical and biological products) and Human Albumin was given new product certificate of State Grade(1994), Lyophilized Human Intravenous Immunoglobulin was given Key New product certificate of state grade (1998). In China, many famous state grade hospitals are keeping using the products produced by our corporation and the quality of the products are given high praise and broad prestige by the users. Moreover, with our strong Research & Development, other products, such as Human Tetanus Immunoglobulin, S/D inactivated frozen plasma, Human Hepatitis B Immunoglobulin will be put into market within 2003. Other new products, such as Human Hepatitis B Immunoglobulin for Intravenous Injection, anti-thrombin III, Prothrombin Complex, anti-lymph Immunoglobulin, a1 anti-trypsinase will be launched into the market in the near future.

If you are interested in our products and need more information about our corporation, don't hesitate to contact us.

Is this your business? Update this listing